AmySanghavi(Sanghavi)ShahMDMD MS FNLA(She/Her)

Pediatric Endocrinology • Cincinnati, OH

Pediatric Diabetes Endocrinology, Pediatric Obesity

Professor, Pediatrics, Cincinnati Children's Hospital Medical Center & The University of Cincinnati College of Medicine

Join to view full profile

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shah's full profile

Already have an account?

Office
3333 Burnet Ave
# ML5012
Cincinnati, OH 45229
Phone+1 513-636-7033

Education & Training

University of CincinnatiMS, Clinical and Translational Research, 2009 - 2011
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Endocrinology, 2007 - 2010
Loyola University Medical CenterResidency, Pediatrics, 2004 - 2007
St. George's University School of MedicineClass of 2004

Certifications & Licensure

OH State Medical License 2007 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology
National Lipid AssociationBoard Certified in Clinical Lipidology

Awards, Honors, & Recognition

Endowed Scholar Cincinnati Children’s Research Foundation, 2022
Fellow Fellow, National Lipid Association, 2020
Young Investigator Award The National Lipid Association, 2016
Young Physician Scientist Award The American Society of Clinical Investigation, 2016
Early Career Development Award The Central Society for Clinical and Translational Research, 2016
Young Investigator Award The International Society of Pediatric and Adolescent Diabetes, 2014
Join now to see all

Clinical Trials

Surgical or Medical Treatment Start of enrollment: 2019 Dec 15
RECRUITING
PHASE4
Roles: Contact, Principal Investigator
Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia Start of enrollment: 2021 Jan 27
COMPLETED
PHASE3
Roles: Principal Investigator

Publications & Presentations

PubMed

A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus.
Xuejun Victor Peng, Georgeanna Klingensmith, Daniel S Hsia, Yunlong Xie, Richard Czerniak
Diabetes Therapy. 2025-03-04
Arterial Stiffness Is Related to Diabetes-Associated Microvascular Complications: The SEARCH for Diabetes in Youth Study.
Ryan P Brady, Elaine M Urbina, Zhiqian Gao, Dana Dabelea, Eva Lustigova
Diabetes Care. 2025-02-14
Glycemia, Insulin Sensitivity, and Secretion Improve 3 Months Post-sleeve Gastrectomy in Youth With Type 2 Diabetes.
Tyler J Dobbs, Melanie G Cree, Alex J Bailey, Amy D Baumgartner, Justin Garrish
Journal of the Endocrine Society. 2025-02-04

Press Mentions

USPSTF Recommends Behavioral Interventions for Kids with High BMIJune 18th, 2024
Weight Loss Surgery May Boost Good Cholesterol in Obese BoysMay 5th, 2016